Effect of genipin on the biliary excretion of cholephilic compounds in rats

Hepatology Research

Volumn 38, Issue 6, 2008, Pages 614-621

  Mikami, Masaki ^a   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bile acids; Bile salt export pump; Biliary excretion; Genipin; Multidrug resistance protein 2; Organic anion

Indexed keywords

BILE SALT; BROMSULFOPHTHALEIN; COLCHICINE; GENIPIN; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 2; PRAVASTATIN; TAUROCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; BILIARY EXCRETION; CANNULATION; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG EXCRETION; DRUG STRUCTURE; INTRAHEPATIC BILE DUCT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY; TREATMENT OUTCOME;

EID: 43049121014     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00309.x     Document Type: Article

References (34)

1. Paulusma CC, Bosma PJ, Zaman GJ et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126-8.
2. Paulusma CC, Kool M, Bosma PJ et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997; 25: 1539-42.
3. Hayashi H, Wakusawa S, Yano M, Okada T. Genetic background of Japanese patients with adult-onset storage diseases in the liver. Hepatol Res 2007; 37: 777-83.
4. Watanabe N, Takashimizu S, Kojima S et al. Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis. Hepatol Res 2007; 37: 598-607.
5. Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273: 10046-50.
6. Strautnieks SS, Bull LN, Knisely AS et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-8.
7. Yamamoto M, Ogawa K, Morita M, Fukuda K, Komatsu Y. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1. Hepatology 1996; 23: 52-9.
8. Yamashiki M, Mase A, Arai I et al. Effects of the Japanese herbal medicine "Inchinko-to" (TJ135) on concanavalin A-induced hepatitis in mice. Clin Sci 2000; 99: 421-31.
9. Kobayashi H, Horikoshi K, Yamataka A, Lane GJ, Yamamoto M, Miyano T. Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int 2001; 17: 386-9.
10. Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-defined diet. J Hepatol 2003; 38: 762-9.
11. Imanishi Y, Maeda N, Otogawa K et al. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J Hepatol 2004; 41: 242-50.
12. Inao M, Mochida S, Matsui A et al. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J Hepatol 2004; 41: 584-91.
13. Aburada M, Takeda S, Sakurai M, Harada M. Pharmacological studies of gardenia fruit. V. Mechanisms of inhibitory effect of genipin on gastric acid secretion and its facilitatory effect on bile secretion in rats. J Pharmacobiodyn 1980; 3: 423-33.
14. Takeda S, Endo T, Aburada M. Pharmacological studies on iridoid compounds. III. The choleretic mechanism of iridoid compounds. J Pharmacobiodyn 1981; 4: 612-23.
15. Miyagoshi M, Amagaya S, Ogihara Y. Choleretic actions of iridoid compounds. J Pharmacobiodyn 1988; 11: 186-90.
16. Yamamoto M, Miura N, Ohtake N et al. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of fas-induced lethal liver apoptosis in mice. Gastroenterology 2000; 118: 380-9.
17. Shoda J, Miura T, Utsunomiya H et al. Genipin enhances Mrp2 (Abcc2) -mediated bile formation and organic anion transport in rat liver. Hepatology 2004; 39: 167-78.
18. Okada K, Shoda J, Kano M et al. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1450-63.
19. Ballatori N, Rebbeor JF. Roles of Mrp2 and oatp1 in hepatocellular export of reduced glutathione. Semin Liver Dis 1998; 18: 377-87.
20. Kanai S, Kitani K. Effect of tauroursodeoxycholate on the biliary transport maximum of sulfobromophthalein in the rat. J Lab Clin Med 1986; 108: 601-7.
21. Dubin M, Maurice M, Feldmann G, Erlinger S. Influence of colchicine and phalloidin on bile secretion and hepatic ultrastructure in the rat. Gastroenterology 1980; 79: 646-54.
22. Tachizawa H, Sano N, Takikawa H. Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats. J Gastroenterol Hepatol 2004; 19: 1016-22.
23. Takikawa H, Sano N, Narita T et al. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 1991; 14: 352-60.
24. Fukumura S, Takikawa H, Yamanaka M. Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat. Pharmaceut Res 1998; 15: 72-6.
25. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Application to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-22.
26. Takikawa H, Wako Y, Sano N, Yamanaka M. Changes in biliary excretory mechanisms in bile duct-ligated rat. Digest Dis Sci 1993; 41: 256-62.
27. Akashi M, Tanaka A, Takikawa H. Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats. Hepatol Res 2006; 34: 193-8.
28. Takikawa H, Sano N, Wako Y, Yamanaka M. Effects of organic anions and bile acids on biliary lipid excretion in hyperbilirubinemic mutant Sprague-Dawley rats. J Hepatol 1993; 17: 247-52.
29. Takikawa H, Fujiyoshi M, Sano N, Yamanaka M. Effects of organic anions on biliary glutathione excretion in rat. Pharmacology 1996; 53: 114-22.
30. Fickert P, Zollner G, Fuchsbichler A et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001; 121: 170-83.
31. Paulusma CC, van Geer NA, Evers R et al. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999; 338: 393-401.
32. Rebbeor JV, Connolly CC, Ballatori N. Inhibition of Mrp2-and Ycf1p-mediated transport by reducing agents: Evidence for GSH transport on rat Mrp2. Biochim Biophys Acta 2002; 1559: 171-8.
33. Ito K, Koresawa T, Nakano K, Horie T. Mrp2 is involved in benzylpenicillin-induced choleresis. Am J Physiol Gastrointest Liver Physiol 2004; 287: G42-9.
34. Fernandez-Checa JC, Takikawa H, Horie T, Ookhtens M, Kaplowitz N. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem 1992; 267: 1667-73.